Web1 jul. 2024 · Sudden cardiac death is one of the leading causes of death in the older population. Compared with the general population, patients who experienced a … Web29 jan. 2024 · An Arresting Idea to Save Lives. Every year in the United States, approximately 350,000 people experience sudden cardiac arrest outside of a hospital setting. When it happens, it sets in motion an urgent race against time that could result in an individual’s death within a matter of minutes. “The problem with cardiac arrest is, time is …
ASSURE Wearable Cardioverter Defibrillator System Kit (P/N …
WebDevice: ASSURE Wearable Cardioverter Defibrillator (WCD) System: Generic Name: wearable automated external defibrillator: Applicant: Kestra Medical Technologies, Inc. WebSponsored Content. The ASSURE ® Wearable Cardioverter Defibrillator (WCD) system from Kestra Medical Technologies provides important advantages based on patient … human rights easy read uk
Wearable cardioverter-defibrillators after myocardial infarction: a ...
WebKestra Medical Technologies, Inc. is a privately held wearable medical device and digital healthcare company that protects cardiac patients with diagnostic monitoring and … WebHeadquarters Regions Greater Seattle Area, West Coast, Western US. Founded Date 2014. Operating Status Active. Last Funding Type Private Equity. Company Type For Profit. Contact Email [email protected]. Phone Number (425) 279-8002. Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects ... Web27 sep. 2024 · Background: Despite the high rate of sudden death after myocardial infarction among patients with a low ejection fraction, implantable cardioverter-defibrillators are contraindicated until 40 to 90 days after myocardial infarction. Whether a wearable cardioverter-defibrillator would reduce the incidence of sudden death during this high-risk … human rights easy read ireland